| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;70:140-144
© 2000 The Society of Thoracic Surgeons
a Department of Cardiac Research, Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
b Department of Cardiac Surgery, Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Address reprint requests to Dr Mayer, Department of Cardiac Surgery, Children’s Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 02115
Background. Tissue engineering is a new approach, whereby techniques are being developed to transplant autologous cells onto biodegradable scaffolds to ultimately form new functional tissue in vitro and in vivo. Our laboratory has focused on the tissue engineering of heart valves, and we have fabricated a trileaflet heart valve scaffold from a biodegradable polymer, a polyhydroxyalkanoate. In this experiment we evaluated the suitability of this scaffold material as well as in vitro conditioning to create viable tissue for tissue engineering of a trileaflet heart valve.
Methods. We constructed a biodegradable and biocompatible trileaflet heart valve scaffold from a porous polyhydroxyalkanoate (Meatabolix Inc, Cambridge, MA). The scaffold consisted of a cylindrical stent (1 x 15 x 20 mm inner diameter) and leaflets (0.3 mm thick), which were attached to the stent by thermal processing techniques. The porous heart valve scaffold (pore size 100 to 240 µm) was seeded with vascular cells grown and expanded from an ovine carotid artery and placed into a pulsatile flow bioreactor for 1, 4, and 8 days. Analysis of the engineered tissue included biochemical examination, enviromental scanning electron microscopy, and histology.
Results. It was possible to create a trileaflet heart valve scaffold from polyhydroxyalkanoate, which opened and closed synchronously in a pulsatile flow bioreactor. The cells grew into the pores and formed a confluent layer after incubation and pulsatile flow exposure. The cells were mostly viable and formed connective tissue between the inside and the outside of the porous heart valve scaffold. Additionally, we demonstrated cell proliferation (DNA assay) and the capacity to generate collagen as measured by hydroxyproline assay and movat-stained glycosaminoglycans under in vitro pulsatile flow conditions.
Conclusions. Polyhydroxyalkanoates can be used to fabricate a porous, biodegradable heart valve scaffold. The cells appear to be viable and extracellular matrix formation was induced after pulsatile flow exposure.
This article has been cited by other articles:
|
|
 |
|
  J. E. Mayer Tissue Engineering for Cardiac Valve Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 1649 - 1656. [Full Text]
|
|
|
|
 |
|
 R. Sodian, C. Lueders, L. Kraemer, W. Kuebler, M. Shakibaei, B. Reichart, S. Daebritz, and R. Hetzer Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells Ann. Thorac. Surg., June 1, 2006; 81(6): 2207 - 2216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yang, R. Sodian, P. Fu, C. Luders, T. Lemke, J. Du, M. Hubler, Y. Weng, R. Meyer, and R. Hetzer In Vitro Fabrication of a Tissue Engineered Human Cardiovascular Patch for Future Use in Cardiovascular Surgery Ann. Thorac. Surg., January 1, 2006; 81(1): 57 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rieder, M.-T. Kasimir, G. Silberhumer, G. Seebacher, E. Wolner, P. Simon, and G. Weigel Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 399 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Filion and C. G. Ellis A finite difference model of O2 transport in aortic valve cusps: importance of intrinsic microcirculation Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2099 - H2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bertipaglia, F. Ortolani, L. Petrelli, G. Gerosa, M. Spina, P. Pauletto, D. Casarotto, M. Marchini, and S. Sartore Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur) Ann. Thorac. Surg., April 1, 2003; 75(4): 1274 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. H. Sutherland and J. E. Mayer Jr. Tissue engineering for cardiac surgery Card. Surg. Adult, January 1, 2003; 2(2003): 1527 - 1536. [Full Text]
|
|
|
|
|
|
T. Scott-Burden, J. P. Bosley, D. Rosenstrauch, K. D. Henderson, F. J. Clubb Jr, H. C. Eichstaedt, K. Eya, I. Gregoric, T. J. Myers, B. Radovancevic, et al. Use of autologous auricular chondrocytes for lining artificial surfaces: a feasibility study Ann. Thorac. Surg., May 1, 2002; 73(5): 1528 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Akins Can Tissue Engineering Mend Broken Hearts? Circ. Res., February 8, 2002; 90(2): 120 - 122. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sun, A. Van Dommelen, J. Van Impe, and J. Vanderleyden Involvement of glnB, glnZ, and glnD Genes in the Regulation of Poly-3-Hydroxybutyrate Biosynthesis by Ammonia in Azospirillum brasilense Sp7 Appl. Envir. Microbiol., February 1, 2002; 68(2): 985 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Weind, D. R. Boughner, L. Rigutto, and C. G. Ellis Oxygen diffusion and consumption of aortic valve cusps Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2604 - H2611. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
